SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GW&K Investment Management, LLC 1,406,158$38,7680.39%
Polar Capital Holdings Plc 1,654,470$45,613,7380.34%
Wakefield Asset Management LLLP 20,874$575,4970.26%
Bellevue Group AG 580,600$16,007,1420.26%
ISTHMUS PARTNERS, LLC 64,472$1,777,4930.26%
KLR INVESTMENT ADVISORS, LLC 7,661$277,5580.25%
CONGRESS ASSET MANAGEMENT CO /MA 917,164$25,286,2110.22%
SCOUT INVESTMENTS, INC. 286,829$7,778,8020.18%
USA FINANCIAL FORMULAS 3,438$94,7860.14%
Virtus Fund Advisers, LLC 714$19,6850.14%
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 346,115$9,542,3910.12%
CAMPBELL NEWMAN ASSET MANAGEMENT INC 42,355$1,167,7270.11%
MACQUARIE GROUP LTD 2,750,856$75,841,0000.10%
BURNEY CO/ 71,711$1,977,0650.09%
Congress Wealth Management LLC / DE / 159,146$4,387,6510.09%
Legato Capital Management LLC 21,472$591,9830.09%
LOOMIS SAYLES & CO L P 1,730,269$47,7030.08%
MERITAGE PORTFOLIO MANAGEMENT 36,067$9940.07%
Epoch Investment Partners, Inc. 387,653$10,687,5930.07%
Renaissance Technologies 1,438,422$39,6570.07%
External links

This page lists SUPERNUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view SUPERNUS PHARMACEUTICALS INC's shareholder history, click here.